242 related articles for article (PubMed ID: 19826974)
81. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
Castro FA; Haimila K; Sareneva I; Schmitt M; Lorenzo J; Kunkel N; Kumar R; Försti A; Kjellberg L; Hallmans G; Lehtinen M; Hemminki K; Pawlita M
Int J Cancer; 2009 Oct; 125(8):1851-8. PubMed ID: 19585495
[TBL] [Abstract][Full Text] [Related]
82. [Acute liver failure due to a treatment by nimesulide].
Altwegg R
Ann Fr Anesth Reanim; 2009 Mar; 28(3):262-3. PubMed ID: 19195818
[No Abstract] [Full Text] [Related]
83. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.
Daly AK; Aithal GP; Leathart JB; Swainsbury RA; Dang TS; Day CP
Gastroenterology; 2007 Jan; 132(1):272-81. PubMed ID: 17241877
[TBL] [Abstract][Full Text] [Related]
84. Human N-acetyltransferases and drug-induced hepatotoxicity.
Makarova SI
Curr Drug Metab; 2008 Jul; 9(6):538-45. PubMed ID: 18680474
[TBL] [Abstract][Full Text] [Related]
85. Predictive genetic testing for drug-induced liver injury: considerations of clinical utility.
Alfirevic A; Pirmohamed M
Clin Pharmacol Ther; 2012 Sep; 92(3):376-80. PubMed ID: 22850601
[TBL] [Abstract][Full Text] [Related]
86. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.
Nicoletti P; Dellinger A; Li YJ; Barnhart H; Phillips E; Chalasani N;
Am J Gastroenterol; 2024 Jan; 119(1):200-202. PubMed ID: 37552102
[TBL] [Abstract][Full Text] [Related]
87. HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin.
Wuillemin N; Adam J; Fontana S; Krähenbühl S; Pichler WJ; Yerly D
J Immunol; 2013 May; 190(10):4956-64. PubMed ID: 23596311
[TBL] [Abstract][Full Text] [Related]
88. Drug induced liver injury: East versus West - a systematic review and meta-analysis.
Low EXS; Zheng Q; Chan E; Lim SG
Clin Mol Hepatol; 2020 Apr; 26(2):142-154. PubMed ID: 31816676
[TBL] [Abstract][Full Text] [Related]
89. Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?
Clare KE; Miller MH; Dillon JF
Curr Hepatol Rep; 2017; 16(3):258-264. PubMed ID: 28856081
[TBL] [Abstract][Full Text] [Related]
90. Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: a systematic review.
Hunt CM
Hepatology; 2010 Dec; 52(6):2216-22. PubMed ID: 21105110
[No Abstract] [Full Text] [Related]
91. Genetic Predisposition to Drug-Induced Liver Injury.
Stephens C; Andrade RJ
Clin Liver Dis; 2020 Feb; 24(1):11-23. PubMed ID: 31753244
[TBL] [Abstract][Full Text] [Related]
92. Polygenic architecture informs potential vulnerability to drug-induced liver injury.
Koido M; Kawakami E; Fukumura J; Noguchi Y; Ohori M; Nio Y; Nicoletti P; Aithal GP; Daly AK; Watkins PB; Anayama H; Dragan Y; Shinozawa T; Takebe T
Nat Med; 2020 Oct; 26(10):1541-1548. PubMed ID: 32895570
[TBL] [Abstract][Full Text] [Related]
93. Predisposition of antituberculosis drug induced hepatotoxicity by cytochrome P450 2E1 genotype and haplotype in pediatric patients.
Roy B; Ghosh SK; Sutradhar D; Sikdar N; Mazumder S; Barman S
J Gastroenterol Hepatol; 2006 Apr; 21(4):784-6. PubMed ID: 16677176
[No Abstract] [Full Text] [Related]
94. Newly identified genetic variants associated with idiosyncratic drug-induced liver injury.
Stolz A
Curr Opin Gastroenterol; 2022 May; 38(3):230-238. PubMed ID: 35645018
[TBL] [Abstract][Full Text] [Related]
95. Comment: history of drug-induced hepatitis and risk of amoxicillin/clavulanate-induced hepatotoxicity.
Boyd IW
Ann Pharmacother; 2001 Dec; 35(12):1677. PubMed ID: 11793648
[No Abstract] [Full Text] [Related]
96. Promiscuous T-cell responses to drugs and drug-haptens.
Yaseen FS; Saide K; Kim SH; Monshi M; Tailor A; Wood S; Meng X; Jenkins R; Faulkner L; Daly AK; Pirmohamed M; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2015 Aug; 136(2):474-6.e8. PubMed ID: 25910715
[No Abstract] [Full Text] [Related]
97. HLA-B*35:01 Allele Is a Potential Biomarker for Predicting Polygonum multiflorum-Induced Liver Injury in Humans.
Li C; Rao T; Chen X; Zou Z; Wei A; Tang J; Xiong P; Li P; Jing J; He T; Bai Z; Yin J; Tan Z; Yu P; Zhou H; Wang J; Xiao X; Ouyang D
Hepatology; 2019 Jul; 70(1):346-357. PubMed ID: 30985007
[TBL] [Abstract][Full Text] [Related]
98. Drug-induced hepatic injury.
Farrell GC
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S242-50. PubMed ID: 9407344
[TBL] [Abstract][Full Text] [Related]
99. A novel cell-based assay for the evaluation of immune- and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury.
Oda S; Matsuo K; Nakajima A; Yokoi T
Toxicol Lett; 2016 Jan; 241():60-70. PubMed ID: 26546780
[TBL] [Abstract][Full Text] [Related]
100. Mechanisms of drug-induced liver injury: from bedside to bench.
Tujios S; Fontana RJ
Nat Rev Gastroenterol Hepatol; 2011 Apr; 8(4):202-11. PubMed ID: 21386809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
